Empaveli 73606-0010
Generic: Pegcetacoplan
Product NDC
73606-0010- Manufacturer
- Apellis Pharmaceuticals, Inc.
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- May 14, 2021
- Listing Expires
- December 31, 2026
- Application
- NDA215014
Need to source Empaveli? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Pegcetacoplan | 1080 mg/20mL |
Drug Class
Complement Inhibitor [EPC]Complement Inhibitor [EPC]Complement Inhibitors [MoA]
Packaging Options(1)
1 VIAL in 1 CARTON (73606-010-01) / 20 mL in 1 VIAL